Abstract
BackgroundAnti-tumor necrosis factor (TNF) therapy is recommended when conventional DMARDs therapy fails to decrease disease activity of rheumatoid arthritis (RA) to at least low disease activity. One of the advantages...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have